Pain in COVID-19 and features of pathogenetic molecular mechanisms
Vol. 30 No. 4 (2022), Review articles
Vol. 30 No. 4 (2022)

Pain in COVID-19 and features of pathogenetic molecular mechanisms

Review articles
https://doi.org/10.35465/30.4.2022.pp28-33
Published March 6, 2023
Simona Bogdanova
Tanya Shivacheva
Medical University Varna
Tsvetoslav Georgiev
Medical University Varna
https://orcid.org/0000-0002-1652-4648
Petar Petrov
Medical University Varna
PDF EN
PDF BG (Български)

Keywords

COVID-19, pain, pathogenetic mechanisms

How to Cite

Bogdanova, S., Shivacheva, T., Georgiev, T., & Petrov, P. (2023). Pain in COVID-19 and features of pathogenetic molecular mechanisms. Rheumatology (Bulgaria), 30(4), 28-33. https://doi.org/10.35465/30.4.2022.pp28-33
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Although it has been almost three years since the World Health Organization (WHO) declared a pandemic, COVID-19 is still an unsolved problem, thereby attracting great scientific interest. The disease has a heterogeneous clinical picture with multiple manifestations from different organs and systems. Currently, COVID-19 is perceived as a polysyndromic inflammatory disease involving not only the respiratory system, but also the musculoskeletal system, the cardiovascular system, the skin, the excretory and the nervous system, and is accompanied by a number of hematological, gastrohepatoenterological and endocrine disorders. Various pain phenomena also appear in the clinical presentation of the disease, often as a single manifestation or in combination with symptoms from different organs and systems. The pathogenesis of pain is complex and there is still no consensus on the exact driving mechanisms. Several different signaling pathways play an important role in the generation of pain impulses and perception. They are different for different types of pain. At this stage, the role of angiotensin-converting enzyme 2 (ACE), the renin-angiotensin system (RAC), angiotensin 2 receptors (AT2R), direct neuronal invasion of the virus, the involvement of pro-inflammatory cytokines, hypoxia, the involvement of macrophages, is discussed. as well as the role of overactivity of the immune system, causing the so-called "cytokine storm". Pain is the result of complex biochemical processes influenced to varying degrees by biological, physiological and social factors. Our knowledge at this stage remains scarce and is the subject of many studies on the key pathogenic mechanisms. Therefore, the purpose of this review is to describe the known mechanisms for the occurrence and persistence of pain in patients with COVID-19, as well as to classify the pain phenomena and present its most common localizations. The diagnosis and treatment of COVID-19 and associated pain should be carried out by a multidisciplinary team of specialists, given the heterogeneous clinical presentation of the disease.

https://doi.org/10.35465/30.4.2022.pp28-33
PDF EN
PDF BG (Български)

References

  1. Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, Keefe FJ, Mogil JS, Ringkamp M, Sluka KA, Song XJ, Stevens B, Sullivan MD, Tutelman PR, Ushida T, Vader K. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020 Sep 1;161(9):1976-1982.
  2. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260
  3. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, Müller MA, Drosten C, Pöhlmann S., 2020
  4. Santos RAS, Sampaio WO, Alzamora AC, et al. The ACE2/Angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7). Physiol Rev. 2018;98:505–553
  5. Alon R, Sportiello M, Kozlovski S, et al. Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19. Nat Rev Immunol. 2021;21:49–64.
  6. Passos-Silva DG, Verano-Braga T, Santos RA. Angiotensin-(1-7): beyond the cardio-renal actions. Clin Sci. 2013;124:443–456.
  7. Nemoto W, Ogata Y, Nakagawasai O, Yaoita F, Tadano T, Tan-No K. Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice. Eur J Pain. 2014;18:1471–1479.
  8. Danser AH, Anand P. The angiotensin II type 2 receptor for pain control. Cell. 2014;157:1504–1506.
  9. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653–1659.
  10. Nemoto W, Yamagata R, Nakagawasai O, et al. Effect of spinal angiotensin-converting enzyme 2 activation on the formalin-induced nociceptive response in mice. Eur J Pharmacol. 2020;872:172950.
  11. Nemoto W, Ogata Y, Nakagawasai O, Yaoita F, Tadano T, Tan-No K. Involvement of p38 MAPK activation mediated through AT1 receptors on spinal astrocytes and neurons in angiotensin II- and III-induced nociceptive behavior in mice. Neuropharmacology. 2015;99:221–231.
  12. Su S, Cui H, Wang T, Shen X, Ma C. Pain: a potential new label of COVID-19. Brain Behav Immun. 2020;87:159–160Danser AH, Anand P. , 2014
  13. Soda K, Nakada Y, Iwanari H, Hamakubo T. AT2 receptor interacting protein 1 (ATIP1) mediates COX-2 induction by an AT2 receptor agonist in endothelial cells. Biochem Biophys Rep. 2020;24:100850.
  14. Satarker and Nampoothiri, 2020; WHO, 2020b Wu, F., Zhao, S., Yu, B. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265–269 (2020)
  15. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C, Nervous system involvement after infection with COVID-19 and other coronaviruses, Brain Behav Immun. 2020 Jul; 87():18-22.
  16. Li Z, Liu T, Yang N, Han D, Mi X, Li Y, Liu K, Vuylsteke A, Xiang H, Guo X, Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain., Front Med. 2020 Oct; 14(5):533-541.
  17. Mihály Balogh, Clarissa Aguilar, Nicholas T. Nguyen, Andrew J. Shepherd, Angiotensin receptors and neuropathic pain, 2021.
  18. Nemoto W, Yamagata R, Nakagawasai O, et al. Effect of spinal angiotensin-converting enzyme 2 activation on the formalin-induced nociceptive response in mice. Eur J Pharmacol. 2020;872:172950
  19. Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis. Otolaryngology–Head and Neck Surgery. 2020;163(1):3-11 Wu et al., 2020a
  20. Mark A Ellul, Laura Benjamin, Bhagteshwar Singh, Suzannah Lant, Benedict Daniel Michael, Ava Easton, Rachel Kneen, Sylviane Defres, Jim Sejvar, Tom Solomon, Neurological associations of COVID-19, The Lancet Neurology,Volume 19, Issue 9, 2020, Pages 767-783 Rogers et al., 2020
  21. Yeshun Wu, Xiaolin Xu, Zijun Chen, Jiahao Duan, Kenji Hashimoto, Ling Yang, Cunming Liu, Chun Yang, Nervous system involvement after infection with COVID-19 and other coronaviruses, Brain, Behavior, and Immunity, Volume 87, 2020, Pages 18-22, ISSN 0889-1591
  22. Jonathan P Rogers, Edward Chesney, Dominic Oliver, Thomas A Pollak, Philip McGuire, Paolo Fusar-Poli, Michael S Zandi, Glyn Lewis, Anthony S David, Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic, The Lancet Psychiatry, Volume 7, Issue 7, 2020, Pages 611-627
  23. Nabavi N., Long covid: How to define it and how to manage it, : BMJ 2020;370:m3489
  24. Toscano et al., Social Isolation and Stress as Predictors of Productivity Perception and Remote Work Satisfaction during the COVID-19 Pandemic: The Role of Concern about the Virus in a Moderated Double Mediation; Sustainability 2020, 12(23), 9804,
  25. Arnaud Valent, Emmanuel Dudoignon, Quentin Ressaire, François Dépret, Benoît Plaud, Three-month quality of life in survivors of ARDS due to COVID-19: A preliminary report from a French academic centre, Anaesthesia Critical Care & Pain Medicine, Volume 39, Issue 6, 2020, Pages 740-741
  26. Neurath MF, COVID-19 and immunomodulation in IBD., Gut. 2020 Jul; 69(7):1335-1342.
  27. Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768
  28. Krames ES. The dorsal root ganglion in chronic pain and as a target for neuromodulation: a review. Neuromodulation. 2015;18:24–32
  29. Yu X, Liu H, Hamel KA, et al. Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain. Nat Commun. 2020;11:264Hayakawa K, Esposito E, Wang X, et al. , 2016
  30. Hayakawa, K., Esposito, E., Wang, X. et al. Transfer of mitochondria from astrocytes to neurons after stroke. Nature 535, 551–555, 2016
  31. Hayakawa K, Wang X, Lo EH. CD200 increases alternatively activated macrophages through cAMP-response element binding protein - C/EBP-beta signaling. J Neurochem. 2016;136:900–906
  32. Karnam G, Rygiel TP, Raaben M, et al. CD200 receptor controls sex-specific TLR7 responses to viral infection. PLoS Pathog. 2012;8:e1002710
  33. Lau SKP, Lau CCY, Chan KH, et al. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel middle east respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol. 2013;94:2679–2690
  34. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069
  35. Oxford JS, Leuwer M, Acute sore throat revisited: clinical and experimental evidence for the efficacy of over-the-counter AMC/DCBA throat lozenges, Int J Clin Pract. 2011 May; 65(5):524-30.
  36. Wang R, Pan M, Zhang X, Han M, Fan X, Zhao F, Miao M, Xu J, Guan M, Deng X, Chen X, Shen L, Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China, Int J Infect Dis. 2020 Jun; 95():421-428
  37. Leung C, Risk factors for predicting mortality in elderly patients with COVID-19: A review of clinical data in China, Mech Ageing Dev. 2020 Jun; 188():111255
  38. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802.Reamy BV, Williams PM, Odom MR, 2017
  39. Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009
  40. Reamy BV, Williams PM, Odom MR. Pleuritic chest pain: sorting through the differential diagnosis. Am Fam Physician. 2017;96(5):306–312.
  41. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–260
  42. Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020.
  43. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831–1833.e1833
  44. Moustaki M, Zeis PM, Katsikari M, et al. Mesenteric lymphadenopathy as a cause of abdominal pain in children with lobar or segmental pneumonia. Pediatr Pulmonol. 2003;35(4):269–273
  45. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005;5(11):718–725.
  46. Bogdanova-Petrova S, Georgiev T, Shivacheva T, et al., Rheumatic Manifestations In Covid-19 Patients - Single-Center Experience Amidst The Pandemic, Annals of the Rheumatic Diseases 2021; (pos1224), 80:896.
  47. Kyriakides T, Angelini C, Schaefer J, et al. EFNS review on the role of muscle biopsy in the investigation of myalgia. Eur J Neurol. 2013;20(7):997–1005
  48. Joob B, Wiwanitkit V. Arthralgia as an initial presentation of COVID-19: observation. Rheumatol Int. 2020;40(5):823.
  49. Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020
  50. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506
  51. Neurath MF. Covid-19 and immunomodulation in IBD. Gut. 2020;69:1335–1342
  52. Marchioni E, Minoli L. Headache attributed to infections nosography and differential diagnosis. Handb Clin Neurol. 2010;97:601–626.
  53. Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020.
  54. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069.
  55. Mao L., Wang M.D., Chen S.H., He Q.W., Chang J., Hong C.D., et al., 2020. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv 2020
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Downloads

Download data is not yet available.

Most read articles by the same author(s)